Local view for "http://purl.org/linkedpolitics/eu/plenary/2009-11-12-Speech-4-149"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20091112.17.4-149"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"A genuine public health problem, neurodegenerative diseases and, in particular, Alzheimer’s disease, represent the main diseases for which people over 65 years old require substantial clinical care. Alzheimer’s is a disease that will inevitably become more common with the expected ageing of the European population: seven million Europeans are affected today, and that figure will probably double in the coming decades.
This is why concerted action at EU level is important. This is why the European Parliament is acting as the citizens’ sounding board when it calls for coordinated research efforts in this field via the resolution adopted today. Clearly, priority must be given to a multidisciplinary approach incorporating diagnosis, prevention, treatment and support for patients and their families.
Equally, we must respond to the appeal by researchers to have more volunteers for clinical trials if we want to help ensure that effective medicines for treating cognitive disorders are placed on the market. In this regard, a huge information campaign targeted at families must be carried out.
Another challenge in terms of providing better support for patients and, above all, of delaying the onset of their symptoms is to vary their intellectual activities and to keep their minds active every day."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples